About Genomatix
Genomatix is a Healthcare company based in Munchen (Germany) founded in 1997. It operates as a technologies for genomic data analysis and interpretation are developed. Genomatix has raised $500 thousand across 2 funding rounds from investors including NewVa Capital Partners and Future Cap. The company has since been acquired. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis.
Company details
Founded in 1997 and based in Munich, Germany, Genomatix operates in the genomics sector. Software, hardware, and services are provided for analyzing microarray and next-generation sequencing experiments. Tools such as the Genomatix Genome Analyzer and GenomatixSuite are offered for NGS data processing, genome annotation, and gene regulation studies. Collaborative research, contract services, and training in promoter and microarray analysis are also available.
- Headquarters Munchen, Germany
- Stage Acquired
- SectorsHealthcare
- Website genomatix.com
- Social LinkedIn Facebook
- Total Equity Funding$500K (USD)
in 2 rounds
- Latest Funding Round$500K (USD), Series B
May 2005
- InvestorsNewVa Capital Partners
& 1 more
Funding Insights of Genomatix
Genomatix has successfully raised a total of $500K across 2 strategic funding rounds. The most recent funding activity was a Series B round of $500 thousand completed in May 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 2
- Last Round Series B — $500,000
- Investors Count 2
All 2 funding rounds of Genomatix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2005 | $500,000 | Series B | – | – | |
| Jul 2000 | – | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Genomatix
Genomatix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include NewVa Capital Partners and Future Cap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | newvafund.com | - | |
Early-stage tech and offline companies in China are funded. | – | future-cap.com | Beijing, China |
Investor details for Genomatix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genomatix
3 dated milestones of Genomatix across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Genomatix is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $500K.
Web traffic of Genomatix
Websites that share an audience with Genomatix (genomatix.de).
Websites whose visitors overlap most with Genomatix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nanostring.com | 100% | 94.7K | #498,957 | View details | |
dingo.ucsf.edu | dingo.ucsf.edu | 99% | – | – | – |
| appliedmicroarrays.com | 97% | – | – | View details | |
personalizedmedicine.sfsu.edu | personalizedmedicine.sfsu.edu | 94% | – | – | – |
igs.umaryland.edu | igs.umaryland.edu | 93% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Genomatix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Genomatix (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genomatix
Genomatix was founded in 1997 and raised its 1st funding round 3 years after it was founded.
Genomatix is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Genomatix is a funded company, having raised a total of $500K across 2 funding rounds to date.
Founded in 1997 and based in Munich, Germany, Genomatix operates in the genomics sector. Software, hardware, and services are provided for analyzing microarray and next-generation sequencing experiments. Tools such as the Genomatix Genome Analyzer and GenomatixSuite are offered for NGS data processing, genome annotation, and gene regulation studies. Collaborative research, contract services, and training in promoter and microarray analysis are also available.
Genomatix has 2 investors. Key investors include NewVa Capital Partners, and Future Cap.